Blockchain Registration Transaction Record

GeoVax Labs Announces $4.5 Million Registered Direct Offering for Immunotherapies and Vaccines

GeoVax Labs, Inc. announces a $4.5 million registered direct offering to support the development of immunotherapies and vaccines against cancer and infectious diseases. Learn more about this strategic move and its potential impact on the healthcare industry.

GeoVax Labs Announces $4.5 Million Registered Direct Offering for Immunotherapies and Vaccines

This news matters as it signifies GeoVax Labs, Inc.'s strategic move to secure funding for its clinical-stage biotechnology initiatives. The successful completion of the Offering will enable the company to further develop immunotherapies and vaccines against cancer and infectious diseases, potentially leading to groundbreaking advancements in the healthcare industry.

BlockchainDetails
Contract Address0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71
Transaction ID0x93a6e86ade64aa5759f8587a74e67570bb0f749c332c91a2a2356862b5ecec5a
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital Fingerprintfile_twz-263189c8059df9b2d9bdec2e6d046143